Quick Takeaways
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC filed SCHEDULE 13G for NOVARTIS AG Ordinary Shares (NVS).
- Disclosed ownership: 6.4%.
- Date of event: 30 Sep 2024.
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - 30 Sep 2024 SCHEDULE 13G Report for NOVARTIS AG Ordinary Shares (NVS)
- Reporting Manager
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
- Security
- NOVARTIS AG Ordinary Shares
- Symbol
- NVS
- Shares outstanding
- 2,181,288,547 shares
- Disclosed Ownership
- 139,602,467 shares
- Ownership
- 6.4%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Jul 2025, 16:02:43 UTC
- Date of event
- 30 Sep 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC disclosed 6.4% ownership in NOVARTIS AG Ordinary Shares (NVS) on 30 Sep 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Jul 2025, 16:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 6.4% | 139,602,467 | 126,084,217 | 0 | /s/ Andrew Johnson | Director |